Private Practice and Queensland University of Technology, Brisbane, Queensland, Australia.
University of Houston, Houston, Texas, United States.
Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M184-M203. doi: 10.1167/iovs.18-25977.
Best practice clinical guidelines for myopia control involve an understanding of the epidemiology of myopia, risk factors, visual environment interventions, and optical and pharmacologic treatments, as well as skills to translate the risks and benefits of a given myopia control treatment into lay language for both the patient and their parent or caregiver. This report details evidence-based best practice management of the pre-, stable, and the progressing myope, including risk factor identification, examination, selection of treatment strategies, and guidelines for ongoing management. Practitioner considerations such as informed consent, prescribing off-label treatment, and guides for patient and parent communication are detailed. The future research directions of myopia interventions and treatments are discussed, along with the provision of clinical references, resources, and recommendations for continuing professional education in this growing area of clinical practice.
近视防控的最佳临床实践指南包括了解近视的流行病学、危险因素、视觉环境干预以及光学和药物治疗，还需要具备将特定近视防控治疗的风险和益处转化为患者及其家长或看护人能理解的通俗语言的技能。本报告详细介绍了对近视前期、稳定期和进展期患者的基于循证的最佳管理，包括危险因素识别、检查、治疗策略选择以及持续管理指南。还详细介绍了从业者的考虑因素，如知情同意、开处方标签外治疗以及患者和家长沟通指南。讨论了近视干预和治疗的未来研究方向，并提供了临床参考、资源以及在这一日益增长的临床实践领域继续专业教育的建议。
